New insulin pump system aims to improve blood sugar control
NCT ID NCT06865989
First seen Oct 31, 2025 · Last updated May 23, 2026 · Updated 29 times
Summary
This study tested a new version of the Omnipod insulin pump (SmartAdjust 2.0) against the current Omnipod 5 system in 132 people with type 1 or type 2 diabetes, ages 2 to 70. Participants used each system for about 4 weeks to compare how well they kept blood sugar in a healthy range. The goal was to see if the new system is safe and works better at preventing low and high blood sugar levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1, TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
Diabetes and Glandular Disease Clinic
San Antonio, Texas, 78229, United States
-
Henry Ford
Detroit, Michigan, 48202, United States
-
International Diabetes Center
Minneapolis, Minnesota, 55416, United States
-
Joslin Diabetes Center
Boston, Massachusetts, 02215, United States
-
Northwestern University
Chicago, Illinois, 60611, United States
-
Sansum Diabetes Research Institute
Santa Barbara, California, 93105, United States
-
University Hospitals Cleveland
Cleveland, Ohio, 44106, United States
-
University of Colorado Denver
Aurora, Colorado, 80045, United States
-
University of Southern California
Los Angeles, California, 90022, United States
-
Yale University School of Medicine
New Haven, Connecticut, 06511, United States
Conditions
Explore the condition pages connected to this study.